A 2025 survey of 100 women screened for cervical cancer in Maseru found the average visit cost the patient about 21 international dollars, almost all of it in indirect costs and lost productivity, and that results took a month on average.
Published as "A patient costing analysis of Lesotho's cervical cancer screening program". Women using screening services at the Senkatana Cervical Cancer Center of Excellence between January and November 2025 were asked about direct, indirect and productivity costs to themselves and their caregivers. Costs were converted to international dollars using 2024 purchasing power parity. The authors are at Stellenbosch University.
Medical fees were a small part of what screening cost these women (4%); the rest was indirect costs and lost productivity, and nine in ten had to make a second trip for results. The authors argue that patient costs belong in screening policy and economic evaluations.
About four in ten women of reproductive age in Lesotho report having been screened, in the country where cervical cancer is estimated to be the commonest cancer.
With one oncology clinic in the capital, the cost of cancer care in Lesotho falls on patients as travel, time and tests, and most heavily on people who do not live in Maseru.
Shares Barriers to cancer services reported by patients at the Senkatana oncology clinic, Lesotho, Senkatana Oncology Clinic.
Shares Barriers to cancer services reported by patients at the Senkatana oncology clinic, Lesotho, Cervical cancer screening uptake in Lesotho in the 2024 Demographic and Health Survey, Senkatana Oncology Clinic.
Shares Cervical cancer screening uptake in Lesotho in the 2024 Demographic and Health Survey, Cervical cancer.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/